Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.991 | 419 | 0 | 1993 | 2020 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.983 | 396 | 0 | 1996 | 2020 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 0.963 | 243 | 0 | 1988 | 2020 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.400 | strong | 0.958 | 143 | 0 | 1982 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.400 | None | 0.986 | 142 | 0 | 1990 | 2020 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.400 | None | 0.970 | 100 | 0 | 1987 | 2020 | ||||||||
|
myosin heavy chain 11 | 0.528 | 0.731 | 0.77 |
|
disease | 0.500 | None | 0.960 | 99 | 0 | 1995 | 2020 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
disease | 0.100 | None | 0.968 | 95 | 0 | 1989 | 2020 | ||||||||
|
nucleoporin 98 and 96 precursor | 0.532 | 0.577 | 1.00 |
|
disease | 0.400 | None | 0.960 | 95 | 0 | 1996 | 2019 | ||||||||
|
homeobox A9 | 0.521 | 0.692 | 4.4E-05 |
|
disease | 0.400 | None | 0.987 | 76 | 0 | 1996 | 2020 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.928 | 68 | 0 | 1989 | 2019 | ||||||||
|
C-C motif chemokine receptor 7 | 0.443 | 0.769 | 5.8E-02 |
|
disease | 0.100 | None | 0.985 | 65 | 0 | 1992 | 2019 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.400 | None | 0.985 | 65 | 0 | 1985 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 59 | 0 | 2006 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.983 | 58 | 0 | 2006 | 2019 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.967 | 58 | 0 | 1979 | 2019 | ||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
disease | 0.100 | None | 0.983 | 58 | 0 | 1995 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.982 | 56 | 0 | 1988 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.982 | 56 | 0 | 2006 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 1.000 | 56 | 0 | 2006 | 2019 | ||||||||
|
core-binding factor subunit beta | 0.601 | 0.538 | 0.96 |
|
disease | 0.500 | None | 0.966 | 56 | 0 | 1993 | 2020 | ||||||||
|
interleukin 3 receptor subunit alpha | 0.560 | 0.769 | 3.0E-27 |
|
disease | 0.100 | None | 0.982 | 55 | 0 | 2001 | 2019 | ||||||||
|
retinoic acid receptor alpha | 0.470 | 0.846 | 0.96 |
|
disease | 0.100 | None | 0.963 | 54 | 0 | 1993 | 2019 | ||||||||
|
MCL1 apoptosis regulator, BCL2 family member | 0.430 | 0.808 | 0.96 |
|
disease | 0.100 | None | 1.000 | 53 | 0 | 2000 | 2020 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.800 | strong | 0.981 | 52 | 0 | 1995 | 2019 |